Treatment of non-Hodgkin’s lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy

✍ Scribed by Robert T. O’Donnell; David Pearson; Hayes C. McKnight; Ya Peng Ma; Joseph M. Tuscano

• Publisher: Springer-Verlag
• Year: 2009
• Tongue: English
• Weight: 440 KB
• Volume: 58
• Category: Article
• ISSN: 0340-7004
• DOI: 10.1007/s00262-009-0688-5